CDC Preterm Birth Activities
CDC collaborates with national, state, tribal, and territorial organizations and partners to increase awareness of preterm births and its consequences and translate science into clinical and public health practice. Ongoing collaborations involve the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, the March of Dimes, and state-based perinatal quality collaboratives.
CDC’s Division of Reproductive Health is engaged in the following activities:
The Maternal and Child Health Epidemiology Program (MCHEP) assigns epidemiologists and fellows to state, local, and tribal levels to support epidemiologic research and provides scientific information to improve maternal and child health programs and policies.
Smoking during pregnancy increases the risk of health problems for developing babies, including preterm birth, low birth weight, and birth defects of the mouth and lip. Smoking during and after pregnancy also increases the risk of sudden infant death syndrome (SIDS). Additionally, e-cigarettes and other tobacco products containing nicotine (the addictive drug found in tobacco) are not safe to use during pregnancy. Nicotine is a health danger for pregnant women and developing babies and can damage a developing baby’s brain and lungs. Also, some of the flavorings used in e-cigarettes may be harmful to a developing baby. Learn more about e-cigarettes and pregnancy.
Some research also shows that marijuana use during pregnancy is linked to health concerns, including high use of other substances that may impact pregnancy and infant health such as tobacco, and developmental problems in adolescents. Learn more about Substance Use During Pregnancy.
Much of CDC’s maternal and infant health surveillance, data quality improvement, and data linkage efforts revolve around birth certificates, the primary resource for learning about preterm birth rates in the United States. CDC partners with the National Association for Public Health Statistics and Information Systems (NAPHSIS) to promote the accurate recording of gestational age on birth certificates that is critical to calculate the rate of preterm birth, better understand the impact of preterm birth, follow trends, and make recommendations about preventing preterm birth.
Assisted Reproductive Technology (ART) Surveillance
The CDC National ART Surveillance System (NASS) is a nationwide system for monitoring ART use and outcomes. Analysis of NASS data has supported the evidence suggesting a higher risk for certain adverse outcomes, including preterm birth, among women who use ART.
Pregnancy Risk Assessment Monitoring System
The Pregnancy Risk Assessment Monitoring System (PRAMS) is a surveillance project of the CDC and state health departments. PRAMS collects state-specific, population-based data on maternal attitudes and experiences before, during, and shortly after pregnancy. PRAMS data have been used to analyze the characteristics of women who experienced preterm delivery.
National Center for Health Statistics (NCHS)
CDC’s NCHS is the principal health statistics agency of the United States. Through its relationship with vital registration systems throughout the United States, NCHS collects, analyzes, and publishes data on a wide range of health indicators, including preterm birth. For more information, visit the NCHS birth data page.
